Sharkey, Howes & Javer’s Avanos Medical AVNS Stock Holding History

Sharkey, Howes & Javer’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50	Closed	-$2K	–	67
2019 Q2	$2K	Hold	50	–	–	﹤0.01%	183
2019 Q1	$2K	Hold	50	–	–	﹤0.01%	190
2018 Q4	$2K	Hold	50	–	–	﹤0.01%	188
2018 Q3	$3K	Hold	50	–	–	﹤0.01%	198
2018 Q2	$3K	Hold	50	–	–	﹤0.01%	186
2018 Q1	$2K	Hold	50	–	–	﹤0.01%	182
2017 Q4	$2K	Sell	50 -50	-50%	-$2.3K	﹤0.01%	186
2017 Q3	$4K	Hold	100	–	–	﹤0.01%	172
2017 Q2	$4K	Hold	100	–	–	﹤0.01%	170
2017 Q1	$4K	Hold	100	–	–	﹤0.01%	185
2016 Q4	$4K	Hold	100	–	–	﹤0.01%	183
2016 Q3	$3K	Hold	100	–	–	﹤0.01%	191
2016 Q2	$3K	Hold	100	–	–	﹤0.01%	197
2016 Q1	$3K	Hold	100	–	–	﹤0.01%	210
2015 Q4	$3K	Hold	100	–	–	﹤0.01%	211
2015 Q3	$3K	Sell	100 -19	-16%	-$663	﹤0.01%	205
2015 Q2	$5K	Sell	119 -22	-16%	-$987	﹤0.01%	171
2015 Q1	$7K	Buy	+141	New	+$6.53K	﹤0.01%	185

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sharkey, Howes & Javer's AVNS Position: Q3 2019 in Review

Sharkey, Howes & Javer sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 50 shares — an estimated $2K sold.

Sharkey, Howes & Javer first reported a position in AVNS in Q1 2015 and held it in 18 quarters. The position peaked at $7K in Q1 2015. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Sharkey, Howes & Javer reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
Sharkey, Howes & Javer sold 50 Avanos Medical shares in Q3 2019, an estimated $2K.
Sharkey, Howes & Javer first reported a position in Avanos Medical in Q1 2015 and held it in 18 quarters.
Sharkey, Howes & Javer's Avanos Medical position peaked at $7K in Q1 2015.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Sharkey, Howes & Javer's 13F filing for Q3 2019, filed 1 Nov 2019.